These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30085460)

  • 21. The evolution of prescription drug monitoring programs.
    Ashburn MA
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):852-3. PubMed ID: 27222197
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethical dimensions of the prescription opioid abuse crisis.
    Stratton TP; Palombi L; Blue H; Schneiderhan ME
    Am J Health Syst Pharm; 2018 Aug; 75(15):1145-1150. PubMed ID: 30045851
    [No Abstract]   [Full Text] [Related]  

  • 23. Community Approaches to the Opioid Crisis.
    Koh H
    JAMA; 2015 Oct; 314(14):1437-8. PubMed ID: 26461987
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety Issues Regarding Prescription Opioids.
    American College of Medical Toxicology
    J Med Toxicol; 2016 Mar; 12(1):142-4. PubMed ID: 26732680
    [No Abstract]   [Full Text] [Related]  

  • 25. An opioid dispensing and misuse prevention algorithm for community pharmacy practice.
    Rickles NM; Huang AL; Gunther MB; Chan WJ
    Res Social Adm Pharm; 2019 Aug; 15(8):959-965. PubMed ID: 29525483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What every dentist should know about opioids.
    Seidman LM; Tordik PA; Bashirelahi N
    Gen Dent; 2017; 65(1):58-61. PubMed ID: 28068268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thinking About Patients in Pain.
    Kennedy MS
    Am J Nurs; 2016 Jul; 116(7):7. PubMed ID: 27336967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription Drug Monitoring Programs: Relationships Among Program Awareness, Use, and State Mandates.
    Williams KS; Magalotti S; Schrouder K; Knox M; Feldman L; Ujwal D; Lynch D
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):129-133. PubMed ID: 30198819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The opioid epidemic: impact on orthopaedic surgery.
    Morris BJ; Mir HR
    J Am Acad Orthop Surg; 2015 May; 23(5):267-71. PubMed ID: 25911660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avoiding an opioid crisis in the UK.
    Levy N; Mills P; Fawcett WJ
    BMJ; 2019 Mar; 364():l1033. PubMed ID: 30858226
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid Expansion of the Opioid Ecosystem: National Implications for Prescriber-Pharmacist Communication.
    Delcher C; Wang Y; Goodin A; Freeman PR; Reisfield GM
    Am J Prev Med; 2018 Nov; 55(5):656-661. PubMed ID: 30219211
    [No Abstract]   [Full Text] [Related]  

  • 32. Providers need to boost efforts to prevent abuse of narcotics.
    Reinke T
    Manag Care; 2014 Apr; 23(4):11-2. PubMed ID: 24868600
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
    Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oregon's strategy to confront prescription opioid misuse: a case study.
    McCarty D; Bovett R; Burns T; Cushing J; Glynn ME; Kruse SJ; Millet LM; Shames J
    J Subst Abuse Treat; 2015 Jan; 48(1):91-5. PubMed ID: 25168199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of narcotics contracts.
    Deep K
    Virtual Mentor; 2013 May; 15(5):416-20. PubMed ID: 23680562
    [No Abstract]   [Full Text] [Related]  

  • 36. Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.
    Garland EL; Howard MO; Zubieta JK; Froeliger B
    Psychother Psychosom; 2017; 86(2):111-112. PubMed ID: 28183077
    [No Abstract]   [Full Text] [Related]  

  • 37. Preventing Prescription Opioid Misuse, Abuse and Overdose in Dentistry.
    Bragg LD
    J Okla Dent Assoc; 2015; 106(3):35-6. PubMed ID: 26480585
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA Boxed Warning for Immediate-Release Opioids.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):141-5. PubMed ID: 27301692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review.
    Balbale SN; Trivedi I; O'Dwyer LC; McHugh MC; Evans CT; Jordan N; Keefer LA
    Dig Dis Sci; 2017 Oct; 62(10):2668-2685. PubMed ID: 28780607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.